Evidence map›Paper›PMID 25342915›Full record

ReviewInternational journal of nephrology and renovascular disease2014

Diabetic nephropathy - complications and treatment.

Andy Kh Lim

2 registry-linked trialsAbstract readReview
In one paragraph

Review in International journal of nephrology and renovascular disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 257 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
257citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02690883 phase4completednot on this mapstarted 2016, after this paper: background citation

Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy: a 24- Week Study

TypeinterventionalSponsorNanfang Hospital, Southern Medical UniversityRan2016 to 2019Enrolled92ConditionsDiabetic NephropathiesArmsExenatide, Lispro
NCT03470415 unknown statusnot on this mapstarted 2018, after this paper: background citation

Relation of Epicardial Fat and Diabetic Nephropathy in Egyptian Patients

Typeobservational_patient_registrySponsorAssiut UniversityRan2018 to 2019Enrolled100ConditionsType2 Diabetes Mellitus
3 · Its place in the literature

Who cites it

257 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Gelatin Hydrolysate from Bigeye Snapper (International journal of molecular sciences · 2026
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

197 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Andy Kh LimDepartment of Nephrology, Monash Medical Center, Monash Health, Clayton, VIC, Australia ; Department of General Medicine, Dandenong Hospital, Monash Health, Clayton, VIC, Australia ; Department of Medicine, Monash University, Clayton, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic nephropathy is a significant cause of chronic kidney disease and end-stage renal failure globally. Much research has been conducted in both basic science and clinical therapeutics, which has enhanced understanding of the pathophysiology of diabetic nephropathy and expanded the potential therapies available. This review will examine the current concepts of diabetic nephropathy management in the context of some of the basic science and pathophysiology aspects relevant to the approaches taken in novel, investigative treatment strategies.

Indexed as

albuminuriadiabetesdiabetic nephropathyinflammationkidney disease

Identifiers

PMID25342915
PMCPMC4206379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.